TLPH News and Press, Talphera Inc. From 03/31/25

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million PR Newswire The U.S. Food and Drug Administration (FDA) agreed to reduce the number of patients ...

Spire Global Inc. Class A (SPIR) is expected to report $-0.97 for Q4 2024 CaliberCos Inc. (CWD) is expected to report $-0.04 for Q4 2024 Progress Software Corporation (PRGS) is expected to report $0.79 for Q1 2025 Nuvve Holding Corp. (NVVE) is expected to report for quarter end 2024-1...

2025-03-30 17:35:00 ET More on AcelRx Pharmaceuticals Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals Historical earnings data for AcelRx Pharmaceuticals Financial information for AcelRx Pharmaceuticals Read the full article on Seeking Alpha ...

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025 PR Newswire SAN MATEO, Calif. , March 26, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceu...

Nu Ride Inc. - Class A (NRDE) is expected to report for quarter end 2024-12-31 Dalrada Financial Corp. (DFCO) is expected to report for quarter end 2024-12-31 HilleVax Inc. (HLVX) is expected to report $-0.38 for Q4 2024 Chewy Inc. Class A (CHWY) is expected to report $0.03 for Q4 202...

Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2024-12-31 Worthington Steel Inc. (WS) is expected to report $0.67 for Q3 2025 General Mills Inc. (GIS) is expected to report $0.95 for Q3 2025 Talphera Inc. (TLPH) is expected to report for Q4 2024 Sensei Biot...

Portage Biotech Inc. (PRTG) is expected to report for Q3 2025 Aimei Health Technology Co. Ltd (AFJK) is expected to report for quarter end 2024-12-31 Generation Bio Co. (GBIO) is expected to report $-0.28 for Q4 2024 TAT Technologies Ltd. (TATT) is expected to report for quarter end 2...

Kodiak Gas Services Inc. (KGS) is expected to report $0.26 for Q4 2024 Kronos Worldwide Inc (KRO) is expected to report $0.11 for Q4 2024 Neonode Inc. (NEON) is expected to report for Q4 2024 Applied Therapeutics Inc. (APLT) is expected to report $-0.18 for Q4 2024 Churchill Capit...

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study PR Newswire Submission of a Prior Approval Supplement for a reduction in the number of patients in the NEPHRO CRRT study is expected within ...